Certain Cancer Therapies May Hold Promise in Treating COPD, Preclinical Study Suggests
Cancer therapies blocking specific protein receptors called ErbB reduced inflammation in animal models of inflammatory diseases — including those affecting the lung — by destroying neutrophils, a type of immune cell, a preclinical study found. According to the researchers, these findings suggest that treatments blocking the activity…